At a number of companies, employees compete on leaderboards to show how much A.I. they’re using. They’re racking up big bills along the way.

CTI-REALM is Microsoft’s open-source benchmark that evaluates AI agents on real-world detection engineering. It measures whether an agent can take cyber threat intelligence (CTI) and produce validated ...

An exclusive conversation with OpenAI’s chief scientist, Jakub Pachocki, about his firm's new grand challenge and the future of AI.

Karpathy's autoresearch and the cognitive labor displacement thesis converge on the same conclusion: the scientific method is being automated, and the knowledge workforce may be the next casualty.

Google just debuted Nano Banana 2, an updated version of its AI image generator. It combines the abilities of Google’s previous release, Nano Banana Pro—like text rendering and web searching—with ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

A heated exchange on Real Time with Bill Maher is drawing attention after Lauren Boebert and James Talarico sparred over religion in public schools. Boebert defended displaying the Ten Commandments in ...

Former US President Barack Obama said he’s seen no evidence that aliens have made contact with Earth, clarifying his position on extraterrestrials after comments he made in a podcast went viral. Obama ...

Boom Supersonic wants to build the world’s first commercial supersonic airliner. Founded in 2014, the company set out to make air travel dramatically faster — up to twice the speed of today’s ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...